Combination therapy for cancers with BRAF mutation

• 收藏
• 分享

专利权人:

Cothera Bioscience; Inc.

发明人:

CHEN, Yiyou,JIANG, Chun

申请号：

AU2019251124

公开号：

AU2019251124A1

申请日:

2019.04.08

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present disclosure provides a combination therapy for treating cancer with BRAF mutations comprising administrating to a subject an effective amount of (a) an epidermal growth factor receptor (EGFR) inhibitor； (b) a mitogen-activated protein kinase (MEK) 1/2 inhibitor； and (c) a cyclin dependent kinase (CDK) 4/6 inhibitor. Also provided are compositions and kits related to the combination therapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/